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MiD51Autosomal recessive early-onset Parkinson's disease ismost often caused bymutations in the genes encoding the
cytosolic E3 ubiquitin ligase Parkin and the mitochondrial serine/threonine kinase PINK1. Studies in Drosophila
models and mammalian cells have demonstrated that these proteins regulate various aspects of mitochondrial
physiology, including organelle transport, dynamics and turnover. How PINK1 and Parkin orchestrate these
processes, and whether they always do so within a common pathway remain to be clariﬁed.
We have revisited the role of PINK1 and Parkin in mitochondrial dynamics, and explored its relation to the
mitochondrial clearance program controlled by these proteins. We show that PINK1 and Parkin promote
Drp1-dependent mitochondrial ﬁssion by mechanisms that are at least in part independent. Parkin-mediated
mitochondrial fragmentation was abolished by treatments interfering with the calcium/calmodulin/calcineurin
signaling pathway, suggesting that it requires dephosphorylation of serine 637 of Drp1. Parkinson's disease-
causing mutations with differential impact on mitochondrial morphology and organelle degradation demon-
strated that the pro-ﬁssion effect of Parkin is not required for efﬁcient mitochondrial clearance. In contrast, the
use of Förster energy transfer imaging microscopy revealed that Drp1 and Parkin are co-recruited to mitochon-
dria in proximity of PINK1 following mitochondrial depolarization, indicating spatial coordination between
these events in mitochondrial degradation. Our results also hint at a major role of the outer mitochondrial
adaptor MiD51 in Drp1 recruitment and Parkin-dependent mitophagy. Altogether, our observations provide
new insight into themechanisms underlying the regulation ofmitochondrial dynamics by Parkin and its relation
to the mitochondrial clearance programmediated by the PINK1/Parkin pathway.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease (PD) is themost frequentmovement disorder and
the second most common neurodegenerative disease after Alzheimer's
disease. Nearly 10% of cases are caused by mutations in at least seven
genes.Mutations in the PARK2 (parkin) and phosphatase and tensin homo-
log (PTEN)-induced putative kinase 1 (PINK1) genes, which encode a
cyosolic E3 ubiquitin-protein ligase and a mitochondrial serine/ology and treatment of neuro-
itié-Salpêtrière Hospital, 75013
795.threonine-protein kinase, account for clinically similar autosomal reces-
sive early-onset forms of the disease [1].
Genetic studies in Drosophila have demonstrated that PARK2
functions downstream of PINK1 in a common pathway that regulates
mitochondrial morphology and dynamics [2–8]. Loss-of-functionmuta-
tions in PARK2 and PINK1 in this model causemitochondrial defects that
are suppressed by increased expression of the mitochondrial ﬁssion-
promoting dynamin-related GTPase Drp1, or by downregulation of the
fusion-promoting GTPases, Mitofusin (Mfn) and OPA1, suggesting that
the PINK1/PARK2 pathway promotes mitochondrial ﬁssion [5–8]. Stud-
ies in mammalian cells have complicated this view, providing evidence
that this pathway regulates processes involved both in mitochondrial
fusion and ﬁssion, with net outcomes on mitochondrial connectivity
depending on the cell context and experimental conditions [7,9–16].
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additional processes related to mitochondrial maintenance, including
mitochondrial biogenesis, transport and calcium homeostasis [17–25];
whether they always act concertedly and within the limits of a shared
pathway to preserve mitochondrial function and cell survival is unclear
[26,27]. Notwithstanding, the cooperative role of these proteins in the
degradation of dysfunctional mitochondria may be the main route by
which they preserve mitochondrial quality. Loss of the mitochondrial
transmembrane potential (ΔΨmit) leads to PINK1-dependent recruit-
ment of Parkin to mitochondria and subsequent ubiquitin-mediated
proteasomal degradation of mitochondrial proteins and mitophagy
[28–34]. This process is preceded by the dynamicmitochondrial remod-
eling, which isolates damaged organelles from the healthy network and
detaches them from cytoskeletal elements [22,35]. The mechanisms
underlying the spatiotemporal coordination of these events remain to
be clariﬁed.
We have explored changes in mitochondrial morphology triggered
by the modulation of PINK1 and Parkin expression, and studied the
consequences of these morphological changes on the mitochondrial
degradation program promoted by these proteins. We report that
Parkin can promote mitochondrial ﬁssion independently of PINK1 and
that this effect depends on pathways involved in Drp1 phosphorylation.
In addition, we provide evidence that loss ofΔΨmit leads to recruitment
of Drp1 to mitochondria in proximity of PINK1 and Parkin, suggesting
that mitochondrial division occurs at sites where the PINK1/Parkin-
dependent mitochondrial clearance program is initiated.
2. Materials and methods
2.1. Cell culture and transfection
Cos-7 cells were maintained in complete Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum
(Invitrogen, Grand Island, NY), 1% L-glutamine (Invitrogen) and 1%
penicillin and streptomycin (Invitrogen) at 37 °C, with 5% CO2 and ade-
quate humidity. The night before transfection, approximately 25,000
cells were plated on 14-mm glass coverslips (Fisher Scientiﬁc,
Germany) in 24-well culture plates (Nunc, Roskilde, Denmark). For
starvation, cells were maintained in Hank's balanced salt solution
(HBSS) for 1 h.
Plasmids used for transfections were: pcDNA3-HA-Parkin (WT or
G328E or R275W) [36], pCB6-HA-mitoGFP [37], pCB6-Myc-Drp1/Drp1
K38A [37], and pcDNA3-V5-His-TOPO (Invitrogen) with PINK1 cDNA
as insert. For RNA interference experiments, the following siRNAs
were used: a PINK1- or Parkin-speciﬁc stealth siRNA (Invitrogen), Mff-
(Qiagen, Valencia, CA), MiD49 and MiD51-speciﬁc siRNAs (Santa Cruz
Biotechnologies, Dallas, TX) and a stealth universal negative control
(Invitrogen). The cells were transfected with plasmids using DMRIE-C
(Invitrogen) or with siRNAs and plasmids using Lipofectamine 2000
(Invitrogen), according to the manufacturer's instructions.
2.2. Pharmacological agents
The protonophore carbonyl cyanide m-chloropheyl hydrazone
(CCCP; Sigma, St. Louis, MO) was applied at 10 μM for the indicated
time periods. The speciﬁc calcineurin (CaN) inhibitor FK506 and the
cAMP elevating agent Forskolin (Forsk) were obtained from Tocris Bio-
science (Minneapolis, MN). The calmodulin (CaM) inhibitor W13 was
from Calbiochem/Millipore (Billerica, MA). EGTA was purchased from
Sigma-Aldrich. Concentrations and treatment times were as indicated.
2.3. Immunocytochemistry
Cells were ﬁxed 48 or 72 h after transfection with 4% formaldehyde
(Sigma-Aldrich) in DMEM for 15 min, rinsed three times with
phosphate-buffered saline (PBS) and permeabilized with 0.2% TritonX-100 (Sigma-Aldrich) in PBS for 10 min. Where indicated, prior to
ﬁxation, the cells were incubated with 500 nM MitoTracker Deep Red
(Invitrogen). The cells were processed with standard immunocyto-
chemical techniques, using primary polyclonal rabbit (anti-Parkin,
1:2000, Millipore; anti-PINK1, 1:2000, Abcam (Cambridge, MA); anti-
PINK1, 1:2500, Novus Biologicals (Littleton, CO); anti-PMPCB, 1:1000,
Dharmacon (Pittsburg, PA)), polyclonal goat (anti-VDAC2, 1:500,
Abcam; anti-HSD17B10, 1:200, Abcam) or monoclonal mouse antibod-
ies (anti-Dlp1, 1:2000, BD Biosciences (San Jose, CA); anti-p62, 1:5000,
Abcam), and secondary anti-mouse, anti-rabbit or anti-goat antibodies
conjugated to Alexa 488 (1:1000 or 1:10000 for FRET analyses,
Invitrogen), Alexa 350 (1:250, Invitrogen), Alexa 568 (1:10000,
Invitrogen), Cy3 (1:1000, Sigma) or Cy5 (1:500, Jackson Immuno-
Research, West Grove, PA). Cells were mounted on glass microscope
slides with ProlongGold mounting medium (Invitrogen).
2.4. Immunoblotting
ForWestern blot analyses, 125,000 cellswere plated thenight before
transfection in six-well culture plates (Nunc). Forty-eight hours after
transfection cells were incubated in lysis buffer containing 20 mM
Hepes, 150 mM KCl, 1.5 mM MgCl2, 0.5% Triton X-100 1% NP40,
phosphatase inhibitors (0.2 mM Na3VO4, 1 mg/ml NaF, 5.4 mg/ml
ß-glycerophosphate) and protease inhibitors (Complete Cocktail,
Roche), pH 7.0. Whole-cell lysates (50 μg) were separated on a 10%
denaturing polyacrylamide gel and electroblotted. The antibodies used
for immunolabeling were: primary mouse monoclonal (anti-Dlp1,
1:2000, BD Biosciences; anti-PINK1, 1:500, Abgent (San Diego, CA);
anti-actin, 1:2000, Abcam), polyclonal rabbit (anti-β-tubulin, 1:10,000,
Abcam; anti-actin, 1:2000, Sigma-Aldrich; anti-phospho-Drp1 (S637),
1:1000, Cell Signaling (Danvers, MA); anti-Mff, 1:500, Abcam; anti-
MiD51, 1:100, Santa Cruz Biotechnologies), polyclonal goat (anti-
MiD49, 1:100, Santa Cruz Biotechnologies). Incubation with horseradish
peroxidase-conjugated or ﬂuorescent secondary anti-mouse, anti-rabbit
or anti-goat antibodies (1:50,000, Jackson ImmunoResearch; 1:10,000,
Li-Cor) was followed by ECL detection of the signals (Pierce, Rockford,
IL) or capture with the Odyssey Imaging (Li-Cor, Lincoln, NE)) system.
2.5. Epiﬂuorescence and confocal microscopy
Fluorescence images were captured using Zeiss Axioplan 2 imaging
ﬂuorescence microscope (Zeiss, Germany) in conjunction with Explora
Nova Fluo'Up image-capturing software (Explora Nova, La Rochelle,
France).
Cells were categorized according to mitochondrial network mor-
phology or lack of VDAC1 immunostaining with a 63× oil objective
(N.A. 1.40). Mitochondrial network morphologies were classiﬁed as:
tubular (category 1); truncated (category 2); fragmented (category 3);
and aggregated (category 4, in cells treated with CCCP). One hundred to
500 cells overproducing each protein of interest were scored from two
to four independent wells per condition in each experiment.
Quantitative analysis of the mitochondrial network morphology, vi-
sualized with MitoTracker or mtGFP, was performed on 15–30 pictures
of cells overproducing the proteins of interest takenwith a 63×oil objec-
tive using ImageJ software (NIH, Bethesda, Maryland), as described
[38–39]. Aspect ratio is the ratio between major and minor axes of each
mitochondrial object, and thus represents its length. Form factor is calcu-
lated as perimeter2/(4π × area) and thus represents a combined evalua-
tion of the length and degree of branching of the mitochondrial network.
For FRET analyses, images of donor and acceptor ﬂuorescence were
acquired before and after photobleaching from 10 to 20 cells per condi-
tion, in each of three independent experiments, with the 63 × oil objec-
tive. A region of interest was drawn with Leica Confocal Software on
randomly chosen areas of acceptor ﬂuorescence and photobleached
with a 543 nm Helium Neon laser for 20 ms. Fluorescence of the
donor was corrected for the decrease in ﬂuorescence intensity due
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intensites (I) were quantiﬁed with ImageJ and FRET efﬁciencies were
determined as follows: % FRET = (ID postbleach – ID prebleach)/ID
postbleach [40–41].
2.6. Statistical analyses
One-wayANOVA followed byHolm–Sidak orDunn'smultiple pairwise
comparisons was used to compare the effect of Drp1 variants within
“Parkin” or “PINK1” conditions (Fig. 2) the effect of treatments in Fig. 3
and Supplementary Figure 1, the effect of Parkin variants in Fig. 7E, or to
compare FRET efﬁciencies between groups in Fig. 8D. One-way ANOVA
on ranks and the Kruskal–Wallis multiple comparison procedure was
used to analyze FRET efﬁciencies in Figs. 8E, 9B andC, and10C, and to com-
pare the effects of different siRNA in Figs. 10B and D. Two-way ANOVA
and the Holm–Sidak multiple pairwise comparison procedure were
used to analyze time-dependent differences between groups in Figs. 1,
5A, 6, 7A–D and effect of treatments between groups in Figs. 4, 5C and
10E. Student's t-test was used to examine the effect of siRNAs in Fig. 10A.
3. Results
3.1. Changes in mitochondrial morphology caused by Parkin and PINK1 are
mediated by Drp1
To explore the effects of PINK1 and Parkin on mitochondrial
morphology, we used a simian kidney ﬁbroblast cell line (COS7), whichFig. 1. The PINK1/Parkin pathway promotes mitochondrial fragmentation in COS7 cells. (A) Ca
Deep Red: category 1 = tubular, category 2 = truncated, category 3 = fragmented; no TF:
PINK1 (blue staining). Scale bar: 10 μm. (B and C) Proportion of cellswith fragmentedmitochon
and lower panels) using the two descriptive parameters, aspect ratio (AR) and form factor (FF
points after transfection of the cells with the indicated expression vectors; in this case, mitoch
performed in duplicate. Error bars represent SEM (*p-value b 0.05; **p-value b 0.02; ***p-valuis well suited for this purpose because of its large cytoplasm and well-
developed mitochondrial network. Classiﬁcation of cells according to mi-
tochondrial network morphology showed a signiﬁcant increase in the
proportion of cells with fragmentedmitochondria associated with Parkin
overproduction (Fig. 1A and B, C, upper graphs). Quantitative image anal-
ysis of mitochondrial morphology in individual cells revealed a modest
but reproducible reduction in the complexity of the mitochondrial
network compatible with mitochondrial fragmentation in cells
overproducing PINK1 or Parkin (Fig. 1B and C, middle and lower graphs).
When overproduced, Drp1 was found throughout the cytosol with
a ﬁlamentous distribution, whereas its dominant negative, GTPase inac-
tive variant, Drp1 K38A, formed cytosolic aggregates (Fig. 2A). Exoge-
nous Drp1 was associated with a reduction in the aspect ratio but not
the form factor of mitochondrial structures in control cells, and it did
not exacerbate the effects of PINK1 and Parkin (Fig. 2A and B). Exoge-
nous Drp1 K38A did not affect mitochondrial morphology per se; how-
ever, it signiﬁcantlymitigated themitochondrial fragmentation induced
by PINK1 and Parkin (Fig. 2B).
3.2. Changes in mitochondrial morphology promoted by Parkin depend on
the phosphorylation status of Drp1 and can occur independently of PINK1
Phosphorylation of serine 637 in the GTPase effector domain of
Drp1 isoform 1 inhibits mitochondrial ﬁssion; S637 phosphorylation is
regulated by the antagonistic effects of protein kinase A (PKA) and the
calcium/calmodulin-dependent phosphatase calcineurin (CaN) [42]
(Fig. 3A). Conversely, phosphorylation of serine 600 of Drp1 isoform 3tegorization of cells according to their mitochondrial network, visualized by Mitotracker
no transfection, Parkin/PINK1: transfection with expression vectors encoding Parkin or
drial networks (upper panels) and analysis ofmitochondrial networkmorphology (middle
) ([38,39] and Section 2), expressed as percentage of the mtGFP control, at different time
ondrial networks were visualized by mtGFP. Results from two independent experiments
e b 0.01).
Fig. 2. Drp1mediates the pro-ﬁssion effects of Parkin and PINK1. (A) Subcellular distribution of exogenous Drp1 or Drp1 K38A and their effects on the morphology of the mitochondrial
network, visualized byMitoTracker in cells overproducing Parkin or PINK1. (B) Quantiﬁcation ofmitochondrialmorphology in cells overproducing PINK1, Parkin, Drp1 orDrp1K38A alone
or in the indicated combinations (AR and FF values are expressed as percentages of Control TF). Control TF: cells transfected with a non-coding vector. Results represent at least three
independent experiments performed in duplicate. Error bars represent SEM (*p-value b 0.05).
2015L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026(which corresponds to serine 637 of isoform 1) is mediated by calcium/
calmodulin-dependent protein kinase Iα and promotes mitochondrial
fragmentation [43]. To investigate the role of the phosphorylation status
of Drp1 in themodiﬁcation of mitochondrial morphology by Parkin, we
analyzed the effect of FK506, a speciﬁc calcineurin inhibitor; forskolin,
an adenylyl cyclase activator;W13, an inhibitor of the upstreamCaN ac-
tivator calmodulin; or EGTA, a calcium chelator (Fig. 3A). We observed
that FK506, forskolin and EGTA treatment led to a signiﬁcant increase
in the abundance of the pool of Drp1 phosphorylated on serine 637; a
similar, although more moderate effect, was observed in cells treated
withW13 (Fig. 3B). These treatments prevented themitochondrial frag-
mentation triggered by exogenous Parkin without overtly perturbingthe appearance of the mitochondrial network in control cells (mtGFP,
Fig. 4A–C). In contrast, starvation resulted in mitochondrial elongation,
as previously reported [44,45], demonstrating the reliability of the
methodologies used here to characterize mitochondrial morphology
(Supplementary Fig. 1).
Silencing of the endogenous PINK1 gene by RNA interference led to
mitochondrial elongation in control cells (Fig. 5A, B), whereas overpro-
duction of PINK1 resulted in mitochondrial fragmentation (Fig. 1C).
After PINK1 depletion, the morphology of the mitochondrial network
in cells overproducing Parkinwas similar to that of control cells (endog-
enous Parkin and PINK1 levels); however, the network remained more
fragmented than in control cells depleted for PINK1, indicating that the
Fig. 3. The phosphorylation status of Drp1 is modulated by signaling pathways that can be targeted by pharmacological agents. (A) Diagram illustrates the key steps of the calcium/
calmodulin (CaM)/calcineurin (CaN), cAMP/PKA and CaM kinase Iα-dependent pathways regulating phosphorylation of Drp1 isoform 1 on S637 (S637-Drp1v1) or of Drp1
isoform 3 on S600 (S600-Drp1v3), and effects of pharmacological agents. Pathways promoting mitochondrial ﬁssion are in blue and pathways inhibiting mitochondrial ﬁssion are
in red. ER = endoplasmic reticulum; in = autoinhibitory domain; = ℗ catalytic site of CaN or CaMKIα liberated by interaction with CaM; GPCR = G protein-coupled receptor;
Gs = stimulatory G protein; AC = adenylate cyclase; cAMP = cyclic AMP; PKA = protein kinase A. (B) Western blot analysis and corresponding quantiﬁcations illustrating the effect
of the indicated treatments on the abundance of S637-Drp1v1 (left graph) and total Drp1 (right graph) pools.
2016 L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026pro-ﬁssion effect of Parkin is at least in part preserved (Fig. 5A). In con-
trast, the effect of exogenous Parkin was inhibited by the calcineurin in-
hibitor FK 506, whether or not PINK1 was present, supporting a role of
the phosphorylation status of Drp1 in the modulation of mitochondrial
morphology by Parkin (Fig. 5B, C).3.3. Drp1 facilitates Parkin-mediated degradation of dysfunctional
mitochondria
The protonophore CCCP inhibits mitochondrial fusion in the short
term [37,46,47], whereas in the long term it triggers PINK1/Parkin-
Fig. 4. Parkin-mediated mitochondrial ﬁssion depends on the phosphorylation status of Drp1. (A) Representative images depict the effect of CaN inhibitor FK506 (1 h of treatment) on
mitochondrial morphology in control cells (mtGFP) or in cells overproducing Parkin (mtGFP+ Parkin); NT: not treated; scale bar: 10 μm. (B) Percentage of transfected cells with tubular
mitochondrial network is visualized by mtGFP (left graph), and mitochondrial network morphology as a percent of control: (untreated mtGFP) in individual cells treated as indicated
(middle and right graphs). (C) Percentage of transfected cellswith tubularmitochondrial network, visualized bymtGFP, following treatmentwith the indicated drugs. Results are collected
from three independent experiments. Error bars represent SEM (***p-value b 0.01).
2017L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026dependent mitochondrial clearance [29–32]. As expected, both in
the presence and absence of Parkin, CCCP treatment led to progressive
mitochondrial fragmentation; this effect was dependent on Drp1, as it
was signiﬁcantly mitigated by Drp1 K38A (Fig. 6A). In the presence of
Parkin, mitochondrial fragmentation was rapidly followed by mito-
chondrial aggregation and recruitment of the autophagy marker p62/
SQSTM1. These processes were not affected by Drp1 K38A (Fig. 6A, B).
In a signiﬁcant proportion of the cells overproducing Parkin, long-
term treatment with CCCP led to clearance of the entire mitochondrial
network, as illustrated by the disappearance of the mitochondrial
matrix marker HSD17B10; Drp1 K38A signiﬁcantly delayed but did
not prevent Parkin-dependentmitochondrial degradation (Fig. 6C, Sup-
plementary Fig. 2).3.4. Parkin-mediated ﬁssion is not required for clearance of dysfunctional
mitochondria
Previous studies have shown that PD-causing PARK2mutations may
differently affect CCCP-induced mitochondrial clearance. For example,
the R275W substitution compromises the ability of Parkin to promote
mitophagy, while G328E sustains this process ([30,31] (Fig. 7D). These
substitutions preserve the typical intracellular distribution of Parkin
without forming aggregates or overtly perturbing the mitochondrial
network ([36] and data not shown). Both substitutions modestly but
signiﬁcantly reduced the ability of Parkin to promote mitochondrial
fragmentation under basal conditions (Fig. 7A). Mitochondrial mor-
phology was similar in control cells and in cells overproducing Parkin
Fig. 5. Parkin promotes mitochondrial ﬁssion independently of PINK1. (A) Left panel: Western blot showing the efﬁciency of the PINK1 knockdown strategy; middle and right panels:
changes in mitochondrial network morphology following siRNA-mediated PINK1 depletion in cells overproducing Parkin or in control cells at different time points after transfection
(percentage of siRNA Ctrl, 12 h). (B) Representative images illustrate the effect of PINK1 depletion on changes in mitochondrial network morphology triggered by Parkin in cells treated
or not (NT) with FK506 (0.5 μM) for 1 h (scale bar: 10 μm.), and (C) corresponding quantiﬁcations. Results represent three independent experiments. Error bars represent SEM
(*p-value b 0.05; **p-value b 0.02; ***p-value b 0.01).
2018 L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026R275W or Parkin G328E. However, in cells overproducing Parkin
R275W, the complexity of the mitochondrial network was also similar
to that of cells producing normal Parkin, indicating that, in contrast to
G328E, this substitution partially preserves the ﬁssion-facilitating effect
of Parkin. The R275W and G328E substitutions also attenuated the
ability of Parkin to promote mitochondrial fragmentation after
CCCP treatment: although the effect was weak, the mitochondrial
network appeared less fragmented in cells overproducing Parkin
R275W or Parkin G328E than in those producing normal Parkinthroughout the duration of the experiment (Fig. 7B, C). The kinetics
of mitochondrial aggregation and the efﬁciency of mitochondrial
clearance were similar for normal Parkin and Parkin G328E. In con-
trast, mitochondrial aggregation was delayed and mitochondrial
clearance compromised in cells producing Parkin R275W (Fig. 7D,
E). These results suggest that the modiﬁcations in mitochondrial
network morphology promoted by Parkin under basal conditions
are dissociated form the role of the protein in mitochondrial
clearance.
Fig. 6. The effects of Parkin on mitochondrial ﬁssion, aggregation and mitophagy are differentially affected by loss of Drp1 activity. (A) Time-dependent effects of CCCP treatment on
mitochondrial morphology in cells overproducing mtGFP, Parkin or Drp1 K38A, alone or in the indicated combinations. Upper graphs: mitochondrial morphology in individual cells;
lower graphs: proportion of cells with fragmented or aggregated mitochondria. Results from four independent experiments performed in duplicate. (B) Autophagy marker
p62/SQSTM1 is recruited to aggregated mitochondria (stained for VDAC1), in cells overproducing Drp1 K38A and Parkin (not shown), after 6 h of treatment with CCCP. N: nucleus.
Scale bar: 10 μm. (C) Progressive loss of mitochondria is evaluated by quantifying the number of cells lacking matrix marker HSD17B10 in cells overproducing Drp1 K38A and Parkin,
alone or in association, after CCCP treatment. Results represent four independent wells of one representative experiment. Ctrl: control cells transfected with an empty vector. Error
bars represent SEM (***p-value b 0.01).
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PINK1 upon induction of mitochondrial clearance
Drp1-dependent mitochondrial ﬁssion and the recruitment of
Parkin by PINK1 to the outer mitochondrial membrane are essential
for effective mitochondrial clearance [33]. We addressed the possibility
that these events are spatially coordinated by exploringmolecular prox-
imities betweenDrp1, Parkin and PINK1 using Förster resonance energy
transfer (FRET)microscopy. FRETmicroscopy is a powerful technique to
detect transient, localized protein–protein interactions in cellulo,
detecting proximity between proteins at a distance of less than 10 nm[40]. We recently used a FRET approach based on the detection of
quenched donor ﬂuorescence after photobleaching of the acceptor,
with donor/acceptor protein pairs labeled with appropriate secondary
antibodies, to demonstrate that Parkin associateswith PINK1 in proxim-
ity of the translocase of the outer mitochondrial membrane under
conditions of mitochondrial import impairment [41].
Under basal conditions, FRET was observed between Drp1
(endogenous or exogenous) and Parkin in mitochondria-rich regions
(Fig. 8A, D). CCCP treatment induced a signiﬁcant increase in FRET efﬁ-
ciency between these proteins in mitochondrial aggregates (Fig. 8B, D).
FRET was only detected after CCCP treatment between Parkin G328E
Fig. 7. PD-causing PARK2mutations differentially affect mitochondrial morphology and clearance. (A) The PD-causing amino acid substitutions R275W and G328E attenuate the ability of
Parkin to promotemitochondrial ﬁssion, as revealed under basal conditions by the analyses of the proportion of cells with fragmented network, or of mitochondrial network morphology
(expressed as percentage of mtGFP control, 24 h) at different time points after transfection. (B, C) Similar analyses conﬁrm themitochondrial ﬁssion-attenuating effect of the R275W and
G328E substitutions throughout the duration of CCCP treatment. These substitutions have differential impact on Parkin-dependentmitochondrial aggregation (D) ormitochondrial clear-
ance (E), evaluated as the proportion of transfected cells lacking mitochondrial staining (VDAC1) after CCCP treatment. NT: cells transfected with a non-coding vector. Results from three
independent experiments (A), from two independent experiments performed in duplicate (B–D) or from one experiment representative of at least three (E). Error bars represent SEM.
Comparisons are versus control (NT) in (E) (*p-value b 0.05; **p-value b 0.02; ***p-value b 0.01).
2020 L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026and Drp1, and it was not detected between Parkin R275W in the pres-
ence or absence of CCCP (Fig. 8C, D). FRET was not observed between
VDAC1 and Parkin, a control donor/acceptor pair (Fig. 8D) [41].
PINK1 silencing abolished FRET between Drp1 and Parkin under
basal conditions and lowered it signiﬁcantly after CCCP treatment,
suggesting that these proteins are co-recruited on mitochondria in
proximity of PINK1 (Fig. 8E). Consistent with this possibility, FRET was
also detected between endogenous PINK1 and Drp1. This interactionwas enhanced following CCCP treatment, possibly due to the expected
stabilization of PINK1 on the outer mitochondrial membrane, resulting
in greater abundance of donor molecules available for FRET (Fig. 9A,
B). FRET efﬁciency between PINK1 and Drp1was also enhanced follow-
ing overproduction of Parkin or Parkin G328E; in contrast, it was not
modiﬁed by Parkin R275W. Depletion of Parkin by RNA interference
abolished FRET between PINK1 and Drp1, indicating that Parkin is
essential for recruitment of Drp1 in proximity of PINK1 (Fig. 9C).
Fig. 8.Drp1 and Parkin associate upon induction ofmitochondrial clearance in a PINK1-dependentmanner. (A) Representative FRET images for exogenousDrp1 (green, donor) and Parkin
(red, acceptor) in untreated COS7 cells. FRET efﬁciencies illustrate the increase in donor ﬂuorescence in individual pixels after photobleaching of the acceptor, represented using
a pseudocolor scale. Mitochondria (pseudocolored in blue) were labeled with Mitotracker DeepRed. E: mean FRET efﬁciency within the region of interest (yellow frame). N: nucleus.
(B, C) Representative FRET images acquired from COS7 cells treated with CCCP for 6 h and (B) stained for endogenous Drp1 and overproducing Parkin or (C) co-overproducing Drp1
and Parkin R275W or Parkin G328E. (D, E) Quantitative FRET analysis for the indicated donor/acceptor pairs in COS7 cells treated or not with CCCP for 6 h and transfected with plasmids
encoding the indicated Parkin variants (D) or with the indicated siRNAs (E). Percentages of COS7 cells displaying FRET are indicated below the histograms. n= 10 cells from one exper-
iment representative of three. Data aremeans± SEM (**p-value b 0.01, ***p-value b 0.001 versus “CCCP−” or “CCCP+” condition of VDAC1/Parkin pair (D) or Drp1/Parkin pair in “PINK1
siRNA” condition (E)); ap-value b 0.01 versus the corresponding “CCCP−” condition. Scale bar: 10 μm.
2021L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–20263.6. Mff, MiD49 and MiD51 mediate recruitment of Drp1 in proximity of
Parkin and PINK1 upon induction of mitochondrial clearance
Several integral proteins of the outer mitochondrialmembrane have
been proposed to act as receptors or adaptors for the recruitment ofDrp1 to the mitochondrial surface [48–52], including mitochondrial
ﬁssion factor (Mff), mitochondrial dynamics proteins of 49 and 51 kDa
(MiD49 and MiD51) [51,52]. We investigated the potential role of
these proteins in the association of Drp1 in proximity of PINK1 and
Parkin and in Parkin-dependent mitophagy in cells treated with CCCP.
Fig. 9.Drp1 is recruited in proximity of PINK1 in a Parkin-dependentmanner. (A) Representative FRET images for the PINK1 (endogenous)/Drp1 (exogenous) donor/acceptor pair in COS7
cells transfectedwith Parkin and treated or notwith CCCP for 6 h. (B, C)Mean FRET efﬁciencies and percentages of cells displaying FRET for the indicated donor/acceptor pairs in COS7 cells
treated or notwith CCCP for 6 h. n=10cells fromone experiment representative of three. Data aremeans±SEM (*p-value b 0.05, **p-value b 0.01, ***p-value b 0.001 versus “CCCP−” or
“CCCP+” condition of PINK1/VDAC2 pair (B) or Drp1/Parkin pair (C); ap-value b 0.001 versus the corresponding “CCCP−” condition (B, C); and #p-value b 0.05, ##p-value b 0.01 versus
“CCCP−” or “CCCP+” of control condition (NT: cells transfected with a non-coding vector) in (B). Scale bar: 10 μm.
2022 L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026To this end, FRET microscopy was used to explore the interaction
between Parkin and Drp1 or PINK1 and Drp1 when Mid49 or
MiD51 expression was reduced by RNA interference. Remarkably,
downregulation of MiD49 or MiD51 led to a dramatic decrease in
Drp1 levels in COS7 cells (Fig. 10A, B). In cells in which Drp1 was still
visible, depletion of either proteins abolished FRET between the Drp1/
Parkin and the PINK1/Drp1 pairs (Fig. 10C). Downregulation of Mff
did not affect Drp1 levels but resulted in loss of FRET for both donor/
acceptor pairs (Fig. 10A–C). To explore the functional signiﬁcance of
these observations, we analyzed the consequence of the depletion of
Mff, MiD49 or MiD51 on mitochondrial ﬁssion and Parkin-dependent
clearance triggered by CCCP. Depletion of MiD49 and MiD51 but not
Mff attenuated mitochondrial fragmentation (Fig. 10D) and mitochon-
drial clearance after 24 h of CCCP treatment (Fig. 10E). Downregulation
ofMiD49 led to a nearly 50% reduction in the proportion of cellswithout
mitochondrial staining, an effect comparable to that of Drp1K38A
(Fig. 5C). Remarkably, downregulation of MiD51 suppressed Parkin-
dependent mitochondrial loss. These observations support a role of
MiD49 or MiD51 in Drp1 recruitment and mitochondrial ﬁssion prior
to mitophagy.4. Discussion
Wehave revisited the roles of Parkin and PINK1 inmitochondrial re-
modeling and investigated their relation to the mitochondrial degrada-
tion program. In the cell model examined, the manipulation of Parkin
and PINK1 expression levels was consistent with a pro-ﬁssion effect of
these proteins; these observations are not only in line with ﬁndings in
Drosophilamodels, but also with more recent observations in primary
hippocampal and dopaminergic neurons [4–6,8,15]. As previously
reported, Parkin and PINK1 promoted changes in mitochondrial mor-
phology via the dynamin-like GTPase Drp1 [11,13–15]; interestingly,
we show that Parkin does so, at least in part, independently of PINK1,
corroborating other studies suggesting that PINK1 and Parkin do not
always act concertedly and may have independent functions in the
regulation of mitochondrial activity and cell survival [26,27,53,54].
PINK1 had a more moderate impact on mitochondrial morphology
than Parkin in overexpression studies. It has been previously reported
that overproduction of PINK1 recruits Parkin to mitochondria, trigger-
ingmitochondrial clearance in the absence ofmitochondrial depolariza-
tion [32,55]. Therefore, PINK1-mediated changes in mitochondrial
Fig. 10. MiD49 and MiD51 are involved in Drp1 recruitment to mitochondria and Parkin-dependent mitophagy. (A) Representative Western blots illustrate the efﬁciency of the
siRNA-mediated downregulation of MiD49, MiD51 and Mff, and Drp1 levels in COS7 cells (upper panels); degree of depletion of MiD49, MiD51 and Mff (lower panels); data are
means ± SEM from three independent experiments. (B) Quantitative analysis of Western blots as in (A), showing Drp1 abundance in cells depleted for MiD49, MiD51 and Mff. Data
are means± SEM from three independent experiments. (C) Mean FRET efﬁciencies and percentages of cells displaying FRET for the indicated donor/acceptor pairs in COS7 cells depleted
forMiD49,MiD51 andMff and treatedwith CCCP for 6 h. n=10 cells from one experiment representative of three. Data aremeans± SEM (***p-value b 0.001 versus siRNA Ctrl condition
within each donor/acceptor pair). (D) Representative images illustrating the morphology of mitochondria stained for the matrix marker PMPCB in cells transfected with control (Ctrl)
siRNA or siRNAs speciﬁc for MiD49, MiD51 and Mff and treated with CCCP (upper panels). Quantiﬁcation of the percentage of cells with fragmented mitochondrial network in the
above experiment illustrates attenuation ofmitochondrial ﬁssion in cells depleted forMiD49 andMiD51. (E)Mitochondrial clearance, estimated as the proportion of transfected cells lack-
ing mitochondrial staining (PMPCB) after CCCP treatment in cells overproducing Parkin, shows a signiﬁcant decrease in cells depleted forMiD49 andMiD51. Data aremeans± SEM from
one representative experiment out of three, performed in triplicate (D, E). ***p-value b 0.001 versus siRNA Ctrl (D) or corresponding “CCCP−” condition (E).
2023L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026morphology may reﬂect mitochondrial fragmentation prior to degrada-
tion. Conversely, mitochondrial elongation following PINK1 depletion
may reﬂect a protective compensatory response to impaired mitochon-
drial quality, similarly to what reported in other stress paradigms,including starvation conditions [44,45]. The ﬁssion-promoting activity
of Parkinmay reﬂect an additional role in the regulation ofmitochondri-
al dynamics, beyond the function of the protein in the degradation
of dysfunctional mitochondria. This possibility is supported by our
2024 L. Buhlman et al. / Biochimica et Biophysica Acta 1843 (2014) 2012–2026integrated analysis of PD-causing Parkin substitutions, showing that
regulation of mitochondrial morphology by Parkin highlighted under
basal conditions is not mandatory for efﬁcient mitochondrial clearance.
Our results suggest that the impact of Parkin on mitochondrial
dynamics depends on the phosphorylation status of Drp1. Phosphoryla-
tion of various serine residues of Drp1 have been reported to regulate
mitochondrial dynamics in different physiological and pathological con-
ditions (e.g. during mitosis, under oxidative stress, nutrient starvation,
or during voltage-dependent calcium channel-associated calcium
signaling) [56]. Phosphorylation of serine 637 in Drp1 human brain iso-
form (isoform 1) by protein kinase A inhibits mitochondrial division,
while dephosphorylation of this residue by the calcium/calmodulin-
dependent phosphatase calcineurin promotes mitochondrial ﬁssion
[42,57–59]. In contrast, phosphorylation by calcium/calmodulin-
dependent protein kinase Iα of the same residue in Drp1 isoform 3
(serine 600) triggers mitochondrial fragmentation [43]. Several other
Drp1 isoforms encoded bymultiple transcripts generated by alternative
splicing have been described (cf. NCBI Reference Sequence Database,
RefSeq), hinting at possible complex interrelationships between differ-
ent molecular mechanisms regulating Drp1 activity. Here, we show
that pharmacological treatments that interfere with or antagonize the
calcium/calmodulin/calcineurin signaling pathway prevent the mito-
chondrial morphological changes induced by Parkin. These treatments
increased the abundance of the pool of Drp1 phosphorylated on serine
637, suggesting that Parkin-mediated ﬁssion requires either calcine-
urin-dependent dephosphorylation or inhibition of PKA-dependent
phosphorylation of this residue. The concomitant phosphorylation
of serine 600 of isoform 3 by calcium/calmodulin-dependent protein
kinase Iα or of other serine residues in other Drp1 isoforms is not
excluded.
In contrast, previous work in a neuroblastoma-derived cell line has
provided evidence that loss of PINK1 activates calcineurin-dependent
Drp1 dephosphorylation, leading to mitochondrial fragmentation [13].
This is but one example of the various antagonistic mechanisms by
which PINK1 and Parkin have been reported tomodulatemitochondrial
morphology in mammalian cells (reviewed by [16]). Accordingly,
Parkin has been shown to promote the ubiquitin-dependent degrada-
tion of the pro-ﬁssion proteins Drp1 and Fis1, and of the mitochondrial
pro-fusion factors, Mfn1 and Mfn2 [14,33,60,61,62]; PINK1 deﬁciency
has been associated with reductions in transcript levels of the ﬁssion
factor Mtp18 [63]. Altogether, these observations illustrate the versatil-
ity of PINK1andParkin andhint at the existence of a complex intertwined
network of direct and indirect mechanisms by which these proteins par-
ticipate in adapting the mitochondrial network to the speciﬁc
requirements of the cell in different physiological and pathological
conditions.
Consistent with previous studies, we showed that Drp1-dependent
ﬁssion is responsible for the fragmentation of the mitochondrial net-
work at early time points following mitochondrial depolarization, and
that it facilitates mitochondrial clearance promoted by Parkin [33,64].
In contrast, Drp1 did not play a role in mitochondrial aggregation or re-
cruitment of the ubiquitin-binding adaptor protein p62/SQSTM1, which
are dispensable for mitochondrial degradation [65,66]. FRET analyses
revealed that the mitochondrial recruitment of Drp1 is coordinated
with that of Parkin following mitochondrial membrane depolarization.
We showed that in cells treated with CCCP, Drp1 is found in proximity
of both Parkin and PINK1 on mitochondria. The interaction between
PINK1 and Drp1was strengthened by the presence of exogenous Parkin
and abolished by its depletion, whereas that between Parkin and Drp1
was weakened by PINK1 silencing. These results suggest that PINK1
and Parkin recruit Drp1 cooperatively. PINK1 accumulation precedes
Parkin translocation to the outermitochondrialmembrane and is there-
fore likely to be a prerequisite for Drp1 recruitment. Whether Drp1 is
recruited in proximity of PINK1 prior to Parkin, or whether Parkin and
Drp1 ﬁrst associate in the cytosol and then translocate to the outer
mitochondrial membrane remains to be determined. The cooperativeeffect between Parkin and PINK1 in Drp1 recruitment was preserved
by the G328E Parkin substitution but compromised by the R275W substi-
tution,which abrogated the ability of the protein to facilitateDrp1 recruit-
ment in proximity of PINK1, as well as its ability to promote mitophagy.
Therefore, association of Drp1 in proximity of PINK1 and Parkin may be
crucial for mitophagy to proceed efﬁciently. Of note, these molecular in-
teractions were also detected under basal conditions, albeit with lower
FRET efﬁciencies, supporting their physiological relevance.
Initiation of mitochondrial clearance requires coordination between
various events controlled by PINK1 and/or Parkin, including degrada-
tion of Mfn1/2 to prevent fusion of dysfunctional mitochondria to the
healthy network [33,60,61]; degradation of the mitochondrial outer
membrane GTPase Miro, to disconnect mitochondria from microtubules
[22]; and recruitment of Atg proteins [67]. The mechanisms underlying
the spatiotemporal orchestration of these events are largely unknown.
Our ﬁndings suggest that sites of Drp1-dependent ﬁssion on depolarized
mitochondria coincide with sites at which Parkin associates with PINK1
to trigger mitochondrial clearance. We have recently shown that Parkin
is recruited by PINK1 in proximity of the TOM machinery [41], raising
the possibility that this protein complex constitutes a molecular scaffold
for the recruitment of the various molecular actors of mitophagy.
Proteins of the outer mitochondrial membrane involved in Drp1
recruitment may associate with this complex. The respective roles and
potential reciprocal relations between putativemitochondrial receptors
of Drp1 are poorly understood [48–52,68]. Our FRET analyses in cells de-
pleted for Mff, MiD49 and MiD51 indicate that each of these proteins
participate to a certain extent in Drp1 recruitment in proximity of
PINK1 and Parkin on depolarized mitochondria, possibly with additive
or cooperative effects. However, only depletion of MiD49 and MiD51
had a signiﬁcant impact on mitochondrial clearance, associated with
impairment of mitochondrial ﬁssion triggered by CCCP, indicating a
preferential role of these adaptors. Consistent with our previous study
[41], these observations show that FRET effects need to be considered
in conjunction with functional readouts, as lack of FRET does not neces-
sarily reﬂect loss of molecular proximities but may be the result of
weakened protein–protein interactions or nonpermissive orientations
of protein partners [40,41]. Remarkably, dowregulation of MiD51
abolished Parkin-dependent mitophagy, supporting a broader role of
this outer mitochondrial membrane protein in this process.
In conclusion, our study adds another piece to the complex puzzle of
mechanisms bywhich Parkinmodulatesmitochondrial dynamics in dif-
ferent conditions, and supports the idea that PINK1 and Parkin have
both cooperative and independent activities in mitochondrial mainte-
nance. The molecular mechanisms behind and the physiological signif-
icance of the mitochondrial ﬁssion-promoting effect of Parkin in basal
conditions remain to be clariﬁed. In addition, future studies will have
to address the precise mechanisms leading to recruitment of Drp1 to
dysfunctional mitochondria, their relation with the speciﬁc steps of
the mitochondrial degradation program mediated by the PINK1/Parkin
pathway, and their possible link to neurodegeneration in autosomal
recessive Parkinson's disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.05.012.Acknowledgements
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